Difference between revisions of "Projects:QuantitativeSusceptibilityMapping"

From NAMIC Wiki
Jump to: navigation, search
(Blanked the page)
Line 1: Line 1:
Quantifying magnetic susceptibility in the brain from the phase of the MR signal
 
provides a non-invasive means for measuring the accumulation
 
of iron believed to occur with aging and neurodegenerative disease.
 
Phase observations from local susceptibility distributions,
 
however, are corrupted by external biasfields, which
 
may be identical to the sources of interest. Furthermore,
 
limited observations of the phase makes the inversion ill-posed. We
 
describe a variational approach to susceptibility estimation that
 
incorporates a tissue-air atlas to resolve ambiguity in the forward model, while eliminating additional biasfields
 
through application of the Laplacian. Results show qualitative improvement
 
over two methods commonly used to infer underlying
 
susceptibility values, and quantitative susceptibility estimates
 
show better correlation with postmortem iron concentrations than
 
competing methods.
 
  
= Description =
 
 
There is increasing evidence that excessive iron deposition in specific regions
 
of the brain is associated with neurodegenerative disorders such as Alzheimer's
 
and Parkinson's disease [1]. The role of iron in the pathogenesis of these diseases
 
remains unknown and is difficult to determine without a non-invasive method
 
to quantify its concentration in-vivo. Since iron is a ferromagnetic substance,
 
changes in iron concentration result in local changes in the magnetic susceptibility of tissue.
 
In magnetic resonance imaging (MRI) experiments, differences
 
in magnetic susceptibility cause perturbations in the local magnetic field, which
 
can be computed from the phase of the MR signal (in a gradient echo sequence, the observed field is proportional to the MR phase).
 
 
 
The field perturbations caused by magnetic susceptibility differences can be
 
modeled as the convolution of a dipole-like kernel with the spatial susceptibility
 
distribution. In the Fourier domain, the kernel exhibits zeros at the magic angle,
 
preventing direct inversion of the fieldmap [2]. Critically, limited observations of
 
the field make the problem ill-posed. The observed data is also corrupted by
 
confounding biasfields (ie. those from tissue-air interfaces, mis-set shims, and other
 
non-local sources). Eliminating these fields is critical for accurate susceptibility
 
estimation since they corrupt the phase contributions from local susceptibility
 
sources.
 
 
 
In general, methods that rely heavily on agreement between observed and
 
predicted field values computed using kernel-based forward models [2,3,4] are
 
inherently limited since they cannot distinguish between low frequency biasfields
 
and susceptibility distributions that are eigenfunctions of the model. Examples
 
of such distributions include constant, linear, and quadratic functions of
 
susceptibility along the main field (ie. 'z') direction. Applying the forward model to
 
these distributions results in predicted fields that are proportional to the local
 
susceptibility sources, but also identical in form to non-local biasfields (ie. those
 
produced by a z-shim). Therefore, removing all low frequency fields prior to
 
susceptibility estimation will eliminate the biasfield as well as fields due to the
 
sources of interest, potentially preventing accurate calculation of the underlying
 
susceptibility values. In contrast, inadequate removal of the biasfield may result
 
in the estimation of artifactual susceptibility eigenfunctions in areas where the
 
biasfield is strong, such as regions adjacent to tissue-air interfaces. This suggests
 
that additional information such as boundary conditions or priors may be necessary to
 
regularize an incomplete forward model and prevent the mis-estimation
 
of low frequency biasfields.
 
 
 
We present a variational approach for Atlas-based Susceptibility Mapping
 
(ASM) that performs simultaneous susceptibility estimation and biasfield
 
removal using the Laplacian operator and a tissue-air susceptibility atlas.
 
In [5,6,7] it was shown that applying the Laplacian to the observed field eliminates
 
non-local biasfields due to mis-set shims and remote susceptibility
 
distributions (ie. the neck/chest).
 
In this method, large deviations from the susceptibility atlas are penalized,
 
discouraging the estimation of artifactual susceptibility eigenfunctions in regions near
 
tissue-air boundaries where the Laplacian may not be sufficient to eliminate the
 
contribution of non-local sources and substantial signal loss corrupts the observed field.
 
Agreement of predicted and observed fields
 
within the brain is also enforced, but deviations in estimated susceptibility values outside the
 
brain are not penalized, allowing values at the boundary to vary from
 
the atlas-based prior to account for unmodeled external field sources (ie. shims).
 
 
= Results =
 
 
The method is evaluated by comparison of susceptibility maps estimated using ASM to results from Susceptibility Weighted Imaging (SWI) and Field Dependent Relaxation Imaging (FDRI). In SWI, a filtered phase map is obtained by applying a high-pass filter to the phase data, and the resulting SWI map is commonly used as a proxy for susceptibility.
 
While SWI has shown some correlation with magnetic susceptibility differences
 
due to iron and other sources, the phase maps it yields are only an indirect
 
measure of susceptibility due to the non-local effects of the convolution kernel.
 
In addition, the filtering process may remove some low frequency fields due to
 
sources inside the brain. In FDRI, R2 maps are acquired at two different field strengths (ie. 1.5
 
and 3 Tesla) and the difference in R2 divided by the difference in field strength
 
gives the FDRI. The mean FDRI in several regions of interest was previously compared
 
to the mean iron concentration obtained from postmortem analysis and showed
 
stronger correlation with iron content than the SWI maps computed for the same
 
subjects. Obtaining FDRI measurements would be impractical for most studies,
 
however, since it requires images to be collected on two separate scanners.
 
In this work, quantitative results are obtained by comparison of mean susceptibility
 
values in the thalamus (TH), caudate (CD), putamen (PT)
 
and globus pallidus (GP) to corresponding results from SWI, FDRI and postmortem data.
 
 
 
ASM results for a young subject are shown in Fig. 1. Column 1 shows the T1
 
structural (row 1) and acquired fieldmap (row 2). Application of the Laplacian
 
to the field map (row 2, column 2) removes substantial B0 inhomogeneities that
 
bias the observed field. The susceptibility atlas is shown in row 1, column 2
 
and estimated external sources are shown in row 1, column 3. The estimated
 
susceptibility map (row2, column 3) shares high frequency structure with the
 
Laplacian of the observed field, while low frequency structure is preserved by
 
enforcing agreement with additional information provided by the atlas-based
 
prior and observed field.
 
 
 
{|
 
|[[File:Fig1 compound lighter v2.png|400px|thumb|Fig. 1: ASM Results.
 
The first column shows the T1 structural image (row 1) and field
 
map (row 2) with substantial inhomogeneity that was obtained from a young subject.
 
Column 2 shows the susceptibility atlas (row 1), in which voxels take continuous values
 
between [0,1] corresponding to susceptibility values between air and tissue. Taking
 
the Laplacian of the fieldmap successfully eliminates biasfields (row 2, column 2).
 
Estimates of external sources are shown in row 1, column 3. The estimated susceptibility
 
map (row 2, column 3) shares similar high frequency structure with the Laplacian of
 
the observed field while low frequency structure is preserved by enforcing agreement
 
with the atlas and observed field.]]
 
|}
 
 
Fig. 2 shows the T1 structural image (row 1, column 1) and results from FDRI (row 1, column 2), SWI (row 1,column 3),
 
and ASM (row 2, column 3) for a young subject. ASM results for 2 elderly
 
subjects are shown in row 2, columns 1-2. The FDRI shows strong constrast between the
 
ROIs and surrounding tissue, but less high frequency structure than the SWI.
 
The SWI retains high frequency phase effects, but indiscriminately removes low
 
order fields from both internal and external sources, resulting in artifactual low
 
frequency structure. The ASM method accurately preserves the high frequency
 
phase effects seen in SWI while showing improved estimation of low order susceptibility
 
distributions. In addition, ASM provides direct estimates of susceptibility
 
values rather than filtered phase values that serve as proxies for susceptibility.
 
 
 
{|
 
|[[File:Fig2 compound lighter.png|400px|thumb|Fig. 2: Comparison of Results.
 
Row 1 shows the T1 structural image (column 1), FDRI
 
(column 2) and SWI (column 3) results for a young subject. ASM results are shown in
 
row 2 for young (column 3) and elderly (columns 1,2) subjects. The FDRI shows strong
 
constrast between ROIs and adjacent tissue, but less high frequency structure than
 
the SWI. The SWI retains high frequency phase effects, but indiscriminately removes
 
low order fields from both internal and external sources, resulting in artifactual low
 
frequency structure. ASM accurately preserves the high frequency structure seen in
 
SWI while showing improved estimation of low order susceptibility distributions.]]
 
|}
 
 
 
Quantitative results from ASM and previously reported results from FDRI
 
and SWI for the same 12 elderly subjects are shown in Fig. 3. The mean
 
susceptibility values (relative to tissue susceptibility) in each ROI from all elderly subjects are plotted
 
against the corresponding iron concentrations from postmortem analysis (only
 
the mean and SD in each ROI was reported in [8]). ASM shows a high
 
correlation with postmortem values, which is comparable to that seen in FDRI and
 
substantially better than the correlation between phase and iron concentration
 
obtained with SWI. In addition, for the structures that we analyzed (TH, CD, PT, and GP), ASM results
 
compare favorably to the correlation between postmortem iron and
 
susceptibility estimates in corresponding ROIs computed from multi-angle acquisitions [4].
 
 
 
{|
 
|[[File:Fig3 elderly compound.png|800px|thumb|Fig. 3: Quantitative Results. The Mean +/- SD iron concentration
 
(mg/100g fresh weight)
 
in each ROI determined from postmortem analysis [17] is plotted on the x-axis. The y-
 
axes show the Mean +/- SD FDRI (s^{-1}/Tesla), Mean +/- SD SWI (radians), and Mean +/- SD
 
ASM susceptibility (ppm). Mean susceptibility values from ASM show a high
 
correlation with the postmortem data, which agrees well with previous results from FDRI
 
and shows improvement over SWI values reported for the same data [5].]]
 
|}
 
 
[1] Zecca L; Youdim MB; Riederer P; Connor JR; and Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci, 5:863{73, Nov 2004.
 
 
[2] Liu T; Spincemaille P; de Rochefort L; Kressler B; and Wang Y. Calculation of susceptibility through multiple orientation sampling (cosmos): a method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in mri. Magn Reson Med, 61:196{204, Jan 2009.
 
 
[3] Wu J; Wang Y de Rochefort L; Liu T; Kressler B; Liu J; Spincemaille P; Lebon V. Quantitative susceptibility map reconstruction from mr phase data using bayesian regularization: validation and application to brain imaging. Magn Reson Med, 63:194{206, Jan 2010.
 
 
[4] Haacke EM; Xu Y; Cheng YC; and Reichenbach JR. Susceptibility weighted imaging (swi). Magn Reson Med, 52:612{8, Sep 2004.
 
 
[5] Ismrm here
 
 
[6] Li L; and Leigh JS. High-precision mapping of the magnetic field utilizing the harmonic function mean value property.
 
J Magn Reson, 148:442-8,Feb 2001.
 
 
[7] Schweser F; Deistung A; Lehr BW; and Reichenbach JR. Quantitative imaging of intrinsic magnetic tissue properties using mri signal phase: an approach to in-vivo brain iron metabolism. Neuroimage, 54:2789-807, Feb 2011.
 
 
[8] Hallgren B; and Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochemistry, 3:41{51, 1958.
 
 
= Key Investigators =
 
 
* MIT: Clare Poynton, Elfar Adalsteinsson, Polina Golland
 
* BWH/Harvard: William Wells
 
* Stanford: Adolf Pfefferbaum, Edith Sullivan
 

Revision as of 21:12, 25 March 2011

Home < Projects:QuantitativeSusceptibilityMapping